#United States #New York #Securities Fraud #Pomerantz #Waldencast

Introduction

The Pomerantz Law Firm has initiated an investigation regarding potential claims from investors of Waldencast plc (NASDAQ: WALD). The focus of this investigation is to determine whether Waldencast, along with some of its top executives and board members, has engaged in securities fraud or other illegal business practices. Investors affected by this situation are encouraged to contact the firm directly to explore their options.

Background on Waldencast

Waldencast plc is a company that has recently drawn attention due to its troubling financial announcements. On November 24, 2025, Waldencast released its financial results for the second quarter of 2025, which included an updated outlook for the full year. The company projected net revenues to be roughly in line with the previous year, 2024, alongside an adjusted EBITDA margin in the high single digits. This forecast contrasts sharply with earlier guidance that predicted mid-teen growth for net revenues and an EBITDA margin in the mid-to-high teens.

Additionally, Waldencast reported a staggering net loss of $185.2 million for the first half of 2025. This loss was primarily attributed to impairment charges of $132.1 million related to its Obagi Medical brand, and another $20 million concerning the Milk Makeup brand. The announcement resulted in a sharp decline in Waldencast's Class A ordinary shares, which dropped $0.20 or 6.49% to close at $2.88 per share on the same day.

Examining the Claims

The investigation by Pomerantz LLP seeks to clarify the circumstances around the financial results and whether they signify an underlying issue of securities fraud. Investors who have suffered losses based on the company’s misleading statements or management's lack of transparency may have grounds for a class action lawsuit. The firm's founder, the late Abraham L. Pomerantz, is recognized as a pioneer in the domain of securities class actions, and his legacy continues as the firm fights for justice for those affected by corporate malfeasance.

Next Steps for Investors

Investors who believe they have been impacted by Waldencast’s financial disclosures are encouraged to reach out to Danielle Peyton at Pomerantz LLP. They can contact her via email at [email protected] or by calling 646-581-9980, extension 7980. Being part of a class action can offer many investors a chance to recoup their losses through collective legal action.

Conclusion

As the investigation unfolds, the implications for Waldencast plc and its investors could be significant. Pomerantz LLP is committed to ensuring that investors have their voices heard and their rights protected in the face of securities fraud. With a track record of successful recoveries in similar cases, the firm is poised to address the claims of those wronged by potential corporate misconduct associated with Waldencast.

For more information about participating in the investigation or joining the class action, visit www.pomlaw.com or contact Danielle Peyton directly.